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ABSTRACT
The relationship between severe-grade cervical lesions and clusters of human papillomavirus (HPV)
genotypes in a taxonomic classification was surveyed in 232 women with previous abnormal cytology.
HPV co-infections were clustered according to phylogenetic criteria. Multiple infections were detected
in 22.0% of the entire sample. Clade A10 (represented by HPV-6 and HPV-11) appeared more
frequently in multiple infections than clade A9, which was represented by five of the most common
high-risk types, including HPV-16. Although HPV-16 was the most frequent genotype, it was not more
prevalent in multiple infections. Abortion and two or more sexual partners were risk-factors associated
with HPV co-infections. Severe cervical dysplasia was associated with co-infections with oncogenic
types from different clades, with the association being significant for the high-risk clades A7 and A9.
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INTRODUCTION
Human papillomavirus (HPV) infects the skin
and mucosal surfaces, with the large number
of different HPV types being associated with
different sites. Approximately 30 specific types
infect the genital area by sexual transmission [1].
HPV types are characterised by DNA similarity
and high levels of genome conservation. Genital
HPV types are classified as high-risk or low-risk,
according to their association with benign or
malign disease [2], and are included in super-
group A, with HPV-6 and HPV-11 (benign types)
being referred to as group or clade A10, while
HPV-16 and HPV-18, which are the commonest
high-risk types for genital cancers, are included in
clades A9 and A7, respectively [3].
Individuals can be infected by several HPV
types, since each clade comprises unrelated
viruses. Populations at high risk for cervical
cancer, and populations with high rates of human
immunodeficiency virus (HIV) infection, tend to
show higher proportions of infections with multi-
ple types, as compared with populations that do
not belong to these risk groups [4]. Epidemiolog-
ical studies suggest that the immune response to
HPV is type-specific [5], but there is no agreement
concerning the influence of infection with multiple
HPV types on cervical carcinogenesis. According
to Trottier et al. [6], infections with multiple HPV
types seem to act synergically in cervical carcino-
genesis. In contrast, Levi et al. [7] reported that
although infection with multiple HPV types was a
frequent finding in Brazilian women infected with
HIV, concomitant infection with three or more
HPV types did not confer an additional risk of
cervical dysplasia in comparison with single ⁄dou-
ble infections, and was not related to more severe
immune suppression. Co-infection with multiple
HPV types, and its implications for the develop-
ment of efficacious HPV vaccines, is a subject of
great interest [8].
In view of these contrasting findings, the aims
of the present study were to analyse the clinical
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significance of multiple HPV infections in the
progression to cervical lesions, to investigate their
association with typical risk-factors, and to deter-
mine the relationship between severe-grade
cervical lesions and individual HPV genotypes.
MATERIALS AND METHODS
Samples
Cervical samples were collected from 238 women between
2000 and 2005. Six samples failed to amplify in PCRs (b-actin
amplification-negative; see below). Methods of recruitment
and data collection for the study have been described previ-
ously [9]. In brief, patients attended the Cervical Pathology
Service of Hospital Universitario Antonio Pedro (Universidade
Federal Fluminense, Nitero´i, RJ, Brazil). These women were
either referred because of previous abnormal cytology results
from public health services, or attended the Cervical Pathology
Service in the hospital for cytological screening. Colpocitology
was performed at the first or subsequent visit, and biopsies
were performed for women with abnormal cervical cytology.
Cervical lesions were classified as normal, HPV infection
(koilocytosis), atypical squamous cells of undetermined
significance, low-grade squamous intra-epithelial lesions,
high-grade squamous intra-epithelial lesions (HSILs, situ
carcinoma), and squamous invasive carcinoma. The Ethics
Committee of the Medical College at the university approved
the protocol for collection of samples and for obtaining
informed consent. Final diagnoses were the result of cytolog-
ical ⁄histological examination. Patients who were diagnosed
with HSIL and cervical cancer were designated as cases.
Patients with a normal ⁄ inflammatory cervix or who were
carrying benign cervical lesions were included as controls.
DNA extraction
Samples were incubated for 4 h at 50C in digestion buffer
(10 mM Tris-HCl, pH 8.3, 1 mM EDTA, pH 8.0, Tween-20
0.5% v ⁄v) containing proteinase K at a final concentration of
400 mg ⁄L. The samples were then extracted with phenol–
chloroform–isoamyl alcohol (25:24:1). DNA was precipitated
with one-tenth the volume of 0.3 M sodium acetate and three
volumes of ice-cold 100% ethanol, washed with ethanol
70% v ⁄v, air-dried and resuspended in 50 lL of sterile water.
PCR procedure
Consensus primers MY09 ⁄ 11, which amplify a 450-bp target
within the L1 region of HPV, were used to detect generic HPV
DNA [10]. Amplification was performed in 50-lL reactions
containing 1· PCR buffer (Invitrogen, Sa˜o Paulo, Brazil),
200 mM dNTPs, 1.5 mM MgCl2, 50 pmol of each primer,
0.25 U of Taq polymerase (Invitrogen) and 5 lL of sample.
PCRs comprised 35 cycles of 94C for 1 min, 55C for 2 min
and 72C for 2 min. The b-actin primers Ac1 and Ac2
(0.1 pmol each) were used to amplify a 330-bp region of
human DNA as an internal sample control [11]. Negative
controls were included in each run. Products were analysed on
agarose 1.3% w ⁄v gels by comparison with a 100-bp DNA
ladder after staining with ethidium bromide.
HPV clustering
HPV typing was performed using primers targeting the E6
gene DNA sequences of HPV-6, HPV-11, HPV-16, HPV-18,
HPV-31, HPV-33, HPV-35, HPV-45 and HPV-58 [12], yielding
230-, 89-, 134-, 119-, 97-, 132-, 186- and 100-bp fragments,
respectively. Negative controls were included in each run.
HPV co-infections were clustered according to phylogenetic
criteria as follows: clade A7—HPV-18 and HPV-45; cla-
de A9—HPV-16, HPV-31, HPV-33, HPV-35 and HPV-58; and
clade A10—HPV-6 and HPV-11 [3].
Statistical analysis
The strength of the association among HPV genotypes in a
patient group and the association with cervical lesions were
assessed by calculating ORs and 95% CIs. The statistical
significance of results was analysed using the chi-square test
for heterogeneity with Yates’ continuity correction. Fisher’s
exact test and the Mantel–Haentzel procedure for trend were
used, when appropriate. The significance level of tests was set
at p 0.05.
RESULTS
The patients were aged 14–82 years (mean
38.2 years). Most (80.5%) were from Rio de
Janeiro state, had a low income status (64.4%),
and had either attended only elementary school
or were reported to be illiterate (53.9%). The most
prevalent ethnic group was non-white (57.8%).
The number of lifetime sexual partners ranged
from one to 30 (mean 3.0), with sexual activity
beginning at an age of 10–29 years (mean
17 years). Most (58.5%) patients stated that they
had one current sexual partner, and 29.0%
reported that they had ungergone an abortion.
In addition to HPV infection, 13.2% of the
patients were suffering from other sexually trans-
mitted diseases.
HPV infection was detected in 77.2%
(179 ⁄ 232) patients, with multiple HPV infections
being detected in 22.0% (51 ⁄ 232). The most
prevalent HPV types, including multiple infec-
tions, were HPV-16 (54.7%), HPV-6 (24.6%),
HPV-18 (16.2%), HPV-11 (7.8%), HPV-35
(7.8%), HPV-58 (7.8%) and HPV-33 (1.7%). The
precise HPV type could not be identified in
11.2% of HPV-positive samples by the specific
primers used; these were referred to as unde-
termined. No cases of infection with HPV-31
were detected. The prevalence of high-risk and
low-risk HPV infections was 58.6% and 10.3%,
respectively. Most (85%) of the HPV-positive
women were infected with high-risk types.
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Co-infecting genotypes were detected in 28.5%
(51 ⁄ 179) of positive cases, with most (98.0%)
involving two HPV types.
Classification of HPV into phylogenetic groups
[3] was used to verify whether one particular type
was more frequent than others in multiple infec-
tions (Table 1). HPV-31 did not appear in either
single or multiple infections, and HPV-45 was
found only in co-infections. Clade A10, which
was represented by only two low-risk genotypes
in this study (HPV-6 and HPV-10), appeared
more frequently in multiple infections than
clade A9, which was represented by five of the
most common high-risk types, including HPV-16.
Notably, apart from HPV-16, which was the most
prevalent genotype, all the remaining types
occurred at increased frequency in multiple infec-
tions.
Only clade A10 genotypes were found in
controls, and clade A10 was also found in the
only association of three clades (A7A9A10). In
spite of the low virulence associated with
clade A10, the members of this group showed
close affinity with high-risk HPV types included
in clade A9. The A9A10 arrangement was the
prevalent pattern of co-infections observed in
this study.
Investigation of the behavioural and socio-
demographical factors associated with multiple
infections revealed that women who had under-
gone an abortion (OR 2.96, 95% CI 1.5–5.7,
p 0.002) and women with two or more lifetime
sexual partners (OR 4.02, 95% CI 1.36–11.83,
p 0.006) were more likely to have HPV co-infec-
tions. In contrast, co-infections were not associ-
ated with the age of first sexual intercourse or
other sexually transmitted diseases. Demo-
graphical factors such as ethnicity did not reach
statistical significance, although non-white wo-
men showed a tendency to acquire at least two
concurrent infections (OR 2.0, 95% CI 0.5–1.00,
p 0.07). Age did not influence the occurrence of
HPV co-infections, so no adjustment for age was
made (Table 2).
To investigate whether HPV co-infections were
associated with a risk of progression to cancer, the
population surveyed was grouped as either cases
or controls. There were 95 (41.8%) cases, includ-
ing 62 HSIL and 33 squamous invasive carcinoma
cases, and 137 (58.2%) controls, comprising 54
normal ⁄ inflammatory, 33 HPV infections, six
atypical squamous cells of undetermined signif-
icance and 44 low-grade squamous intra-epithe-
lial lesion cases. Co-infections were not associated
significantly with the development of severe
cervical lesions (OR 1.11, p 0.76).
In a second approach, the analysis was re-
peated, testing low-risk and high-risk co-infec-
tions vs. only low-risk or only high-risk HPV
types. Again, the results were not significant
(OR 0.89, 95% CI 0.31–2.55, p 0.81). However,
when co-infections with at least two high-risk
HPV types were tested, the risk of developing
cancer almost reached significance in comparison
with clusters combining low-risk and high-risk
types (Table 3). Finally, when the high-risk geno-
types belonging to different clades were exam-
ined, a significant association was found between
Table 1. Prevalence of human papillomavirus (HPV)








6 A10 12 (28.6) 30 (71.4)
11 A10 3 (21.4) 11 (78.6)
16 A9 70 (70.7) 29 (29.3)
31 A9 0 0
33 A9 1 (33.3) 2 (66.7)
35 A9 5 (38.5) 8 (61.5)
58 A9 4 (28.6) 10 (71.4)
18 A7 13 (46.4) 15 (53.6)
45 A7 0 6 (100)
Total 108 (49.3) 111 (50.7)
Table 2. Behavioural and socio-demographical factors




n = 51 (22.0%)
Single
infection,
n = 181 (78.0%) OR (95% CI) p
Abortion
Yes 23 (47.9) 40 (23.7) 2.96 (1.5–5.7) 0.002
No 25 (52.1) 129 (76.3)
Lifetime sexual partners
More than one 44 (91.7) 123 (73.2) 4.02 (1.36–11.83) 0.006
One 4 (8.3) 45 (26.8)
Ethnicity
Non-white 15 (30.6) 77 (45.6) 2.0 (1.0–0.5) 0.07
White 34 (69.4) 92 (54.4)
Family income
0–2 minimum salariesa 14 (28.6) 66 (37.5) 1.50 (0.7–2.9) 0.3




18 (37.5) 82 (48.5) 0.63 (0.33–1.22) 0.19
High school or higher 30 (62.5) 87 (51.5)
Age at first intercourse
£17 years 26 (52.0) 100 (56.5) 0.80 (0.4–1.5) 0.63
>17 years 24 (48.0) 77 (43.5)
Sexually transmitted disease
Yes 7 (14.3) 22 (12.9) 1.1 (0.4–2.8) 0.80
No 42 (85.7) 149 (87.1)
Age
>31 years 34 (67.3) 124 (68.9) 0.90 (0.46–1.71) 0.90
£30 years 17 (33.3) 56 (31.1)
aMinimum salary is c. 140 US dollars (€90)/month.
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co-infections involving clades A7 and A9, with or
without clade A10 genotypes, and severe cervical
disease (Table 4).
DISCUSSION
The present study investigated the presence of
HPV genotypes in multiple infections. Despite
some methodological limitations, e.g., the small
sample size, the detection of a limited number of
HPV types, and the lack of cumulative time-span
information, the findings demonstrate the presence
of eight circulating HPV genotypes, in several
combinations, among a largely HPV-infected fe-
male population. The frequency of multiple infec-
tions (22.8%) in the entire population was higher
than in other selected samples [13,14]. As the mean
age of the patients was >30 years, and there was a
high rate of persistent HPV types, this fact is not
surprising. Similarly, Perrons et al. [15] showed
that patients with persistent infection might have a
higher risk of acquiring multiple infections.
In order to better understand the role of
multiple infections, the association among demo-
graphical and behavioural factors, the risk of
progression to severe cervical lesions and the
pattern of HPV types were examined. Nine
frequent HPV genotypes belonging to super-
group A (mucosal ⁄ genital) were investigated.
These HPV genotypes are linked frequently to
genital warts (HPV-6 and HPV-11) and invasive
cervical cancer (HPV-16, HPV-18, HPV-31,
HPV-33, HPV-35, HPV-45 and HPV-58). The
HPV types were clustered according to phyloge-
netic criteria in order to address the relationship
between their biological properties and their
involvement in co-infections. All of the HPV
types detected were involved in multiple infec-
tions, although to varying degrees (Table 1). At
the phylogenetic clade level, the two genotypes
belonging to clade A10 (low-risk) were present
more frequently in co-infections than were other
genotypes, and particularly clade A9 genotypes.
This observation has not been reported previously
[14].
It was not possible to evaluate whether previ-
ous infection with one HPV type affects the risk of
acquisition of subsequent HPV types. One of the
limitations of the present study was the use of a
cross-sectional design, which precludes the study
of sequential HPV acquisition, since only one
cervical smear was taken from each patient.
However, Thomas et al. [16] reported that, among
co-infections with HPV-6, HPV-11, HPV-16, HPV-
18, HPV-31 and HPV-45, no combination of two
types was more or less likely to be acquired
concurrently than any other two types.
Despite the limited size of the sample, it was
confirmed that genotypes belonging to clade A10
were involved in both intra-clade and inter-clade
combinations (A10A10, A7A10 and A9A10),
showing the ability of this clade to establish
co-infections. The reasons for this ability are
unclear, but could be related to transmission
route and risk-factors. Significant differences
were found with respect to these epidemiological
variables for oncogenic and non-oncogenic types
[17]. The determinants of non-oncogenic HPV
infection involve sexual behaviour [18], but other
factors might also be involved.
In contrast, the most prevalent type, HPV-16,
was involved less frequently in co-infections
(70.7% vs 29.3%, Table 1), regardless of whether
they were related to the same clade. Despite the
small number of single infections caused by the
other members of clade A9, the frequency of each
of these genotypes in co-infections increased.
These interactions could not be explained by the
transmission route, since, as high-risk types, they
shared the same risk-factors in these women [9].
Chatuverdi et al. [19] also found a reduced fre-
quency of HPV-16 in co-infections as compared to
single infections (56.4% vs. 43.6%) in a large
cohort of women with 27 HPV genotypes. It was
Table 4. Association between human papillomavirus
clades causing infections and cases of severe cervical
disease
Infecting clades Cases Controls Total OR (95% CI) p
A7 0 1 1 –
A9 3 2 5 1.60 (0.21–14.21) 0.48
A10 0 7 7 – –
A7A9 11 2 13 5.85 (1.15–39.94) 0.03
A7A10 3 2 5 1.60 (0.21–14.21) 0.48
A9A10 9 10 19 0.96 (0.33–2.37) 0.93
A7A9A10 0 1 1 –
Table 3. Human papillomavirus co-infections and clades







n (%) OR (95% CI) p
A7A7a, A9A9a,
A7A9a, A7A9A10a
16 (64.0) 9 (36.0) 25 (100.0) 2.84 (0.91–8.86) 0.07
A10A10, A7A10, A9A10 10 (38.5) 16 (61.5) 26 (100.0)
aCo-infections involving two high-risk genotypes.
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also reported that clade A9, comprising HPV-16,
HPV-31, HPV-33, HPV-35, HPV-52 and HPV-58
in their study, was less likely to be involved in
multiple infections, although this finding would
lose its significance if HPV-16 was excluded.
Despite the small size of the sample, the present
findings (Table 1) are partially in agreement with
this previous study. Multiple infections involving
the high-risk clade A7, comprising HPV-18 and
HPV-45 in the present study, were found more
frequently than single infections. It is noteworthy
that HPV-45 was seen only in co-infections.
Although the present study was not designed
to search for lack of cross-protection or compet-
itive acquisition, an epidemiological analysis was
conducted to investigate whether known factors
for cervical cancer development played a role in
determining the presence of co-infections.
Although age is an established risk-factor for
persistent HPV infections and cervical neoplasia,
it was not associated significantly with the pres-
ence of two or more HPV types. Since multiple
infections were not associated with cancer, they
were not associated with age. Similarly, the age at
which sexual activity began was not significant.
There was a significant association between co-
infections and the number of sexual partners and
having undergone an abortion. However, the
latter could be interpreted in terms of damage to
the cervical mucosa or a high-risk lifestyle with
frequent sexual activity without protection. It is
also possible that both variables could act
together in facilitating multiple infections. Clus-
ters involving high-risk HPV types were also
associated significantly with abortions. Ethnicity
was a borderline variable in co-infections, and
was considered to be a marker of socio-economic
status, together with schooling and family in-
come. These markers were not significant vari-
ables for multiple infections.
A similar prevalence of single and multiple
infections was detected among women with HSIL
and cancer (cases) and women diagnosed with
normal or benign cervical lesions (controls). Thus,
the risk of cervical cancer in women with multiple
infections did not exceed that in those with single
infections. Although only a few specific primer sets
were used to type the HPV isolates, the results
obtained were consistent with previous findings
[20–22]. Munoz et al. [23] did not find an increased
risk for cervical cancer associated with multiple
infections in a large international study, although
other studies [6,24] have provided evidence
regarding the contribution of co-infections to cer-
vical carcinogenesis. The present study revealed
that coupling of the two high-risk clades A7 and
A9 increased the risk of HSIL and cancer incre-
mentally. Therefore, a combination of HPV geno-
types belonging to different oncogenic clades may
be a prognostic indicator of cervical neoplasia.
The present findings also seem to indicate that
biological properties are more important in cer-
vical pre-cancerous neoplasia and cancer than
classification criteria, although the retrospective
design of the study meant that the temporal
acquisition of more than one HPV type could not
be studied, even in prospective analysis, as
multiple infections could be confused with tran-
sient infections, re-infections or recurrences. It
should also be noted that the restricted size of the
sample could induce bias, as the most prevalent
oncogenic HPV types found in the study were
HPV-16 (clade A9) and HPV-18 (clade A10).
However, some pairs of HPV types were associ-
ated more closely than others. Thus, HPV-16 was
least likely to be part of a co-infection, whereas
HPV-45 was detected only in co-infections. The
relationship between severe cervical lesions and
the A7A9 cluster was therefore not masked by the
single infection frequency. Interactions among
genotypes of clade A10 and the other genotypes
revealed that individual HPV genital types have a
particular tendency to be involved in co-infec-
tions. The reasons for this observation require
further study.
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